People commonly experience some or all of the following side effects after stopping GLP-1 medications, says Goddard: Increased hunger (often noticeably stronger) Food noise, often described as the persistent mental chatter about eating and cravings Weight regain, which research shows can begin within weeks Changes in blood sugar control, particularly for people with type 2 diabetes Loss of some cardiometabolic benefits gained during treatment Improvement in GLP-1-related side effects such as nausea, constipation and bloating Not everyone experiences every one of these changes, and their severity varies widely
One important regulatory update to know is that in December 2024, the FDA confirmed that the tirzepatide shortage had been resolved [1]
Your plan includes unlimited support, meaning you have 24/7 access to specialists who can help you manage side effects as they arise
10.1186/s12864-021-08159-z BMC Genomics
This isnt just about getting a shot
News & World Report Actors - Add None have been identified for this spot